MedPath

The SUGAR-DIP trial; oral medication versus insulin for diabetes in pregnancy

Recruiting
Conditions
Gestational diabetesDiabetes gravidarumZwangerschapsdiabetes
Registration Number
NL-OMON25358
Lead Sponsor
niversity Medical Center Utrecht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
810
Inclusion Criteria

Aged 18 years or over

- Singleton pregnancy

Exclusion Criteria

- Known pre-existent type 1 or type 2 diabetes mellitus

- Severe medical or psychiatric comorbidities

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
umber of infants born large-for-gestational-age (LGA)
Secondary Outcome Measures
NameTimeMethod
• Maternal hypoglycemia<br /><br>• Primary / secondary caesarean section<br /><br>• Pregnancy related hypertensive disorders: pregnancy induced hypertension, preeclampsia<br /><br>• Preterm delivery (<37 weeks of gestation)<br /><br>• Neonatal hypoglycemia: moderate (serum glucose <2.6 mmol/l), severe (serum glucose <2.0 mmol/l)<br /><br>• Neonatal hyperbilirubinemia requiring phototherapy<br /><br>• Neonatal Medium care / NICU admission
© Copyright 2025. All Rights Reserved by MedPath